<DOC>
	<DOCNO>NCT01721980</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerability multiple ascend oral dos GLPG0974 give healthy male subject 14 day , compare placebo . Furthermore , course study , amount GLPG0974 present blood urine ( pharmacokinetics ) well effect GLPG0974 mechanism action-related parameter blood stool sample ( pharmacodynamics ) characterize compare placebo . Also , effect compound glucose tolerance explore well potential cytochrome P450 ( CYP ) 3A4 induction repeat dose GLPG0974 .</brief_summary>
	<brief_title>Multiple Ascending Dose Study GLPG0974 Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy male , age 1850 year BMI 1830 kg/m2 Any condition might interfere procedure test study Drug alcohol abuse Smoking</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>